Innoviz CFO discloses share and option holdings
Innoviz Technologies Ltd. Chief Financial Officer Cegla Eldar Mordechay reports his equity holdings in the company.
Rhea-AI Filing Summary
Innoviz Technologies Ltd. Chief Financial Officer Cegla Eldar Mordechay reports his equity holdings in the company. He directly holds 464,053 Ordinary Shares. In addition, he has share options over multiple blocks of Ordinary Shares, with exercise prices ranging from 0.0569 to 11.5000 and expiration dates between 2027-08-10 and 2032-08-05. The disclosure also notes 189,854 Ordinary Shares issuable upon vesting of restricted share units granted between 2022 and 2025, vesting in quarterly installments through 2029, subject to his continued service. This Form 3 reflects existing beneficial ownership and awards rather than new market transactions.
Positive
- None.
Negative
- None.
Insider Trade Summary
9 transactions reported
Mixed
9 txns
Insider
Cegla Eldar Mordechay
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Share Option | -- | -- | -- |
| holding | Share Option | -- | -- | -- |
| holding | Share Option | -- | -- | -- |
| holding | Share Option | -- | -- | -- |
| holding | Share Option | -- | -- | -- |
| holding | Share Option | -- | -- | -- |
| holding | Share Option | -- | -- | -- |
| holding | Share Option | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Share Option — 469,357 contracts (Direct);
Ordinary Shares — 464,053 shares (Direct)
Footnotes (7)
- F1. Includes 189,854 ordinary shares issuable upon vesting of restricted share units ("RSUs"); of which (a) 5,214 RSUs granted August 9, 2022, vesting in equal quarterly installments through 2026; (b) 16,656 RSUs granted August 1, 2023, vesting quarterly through 2027; (c) 15,480 RSUs granted February 27, 2024, with 3,488 vesting quarterly through 2027 and 11,992 vesting quarterly through 2028; (d) 28,360 RSUs granted August 20, 2024, vesting quarterly through 2028; (e) 16,464 RSUs granted February 25, 2025, vesting quarterly through 2029; (f) 54,688 RSUs granted August 5, 2025, one-fourth vesting on August 5, 2026, remainder RSUs vesting quarterly through 2029; and (g) 52,992 RSUs granted November 11, 2025, one-fourth vesting on November 11, 2026, remainder vesting quarterly through 2029. Vesting is subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Each RSU represents a contingent right to receive one ordinary share.
- F2. No exercise price is applicable.
- F3. Immediately exercisable.
- F4. Share options granted on August 9, 2022. Includes 27,370 vested options, and 3,910 unvested options, which shall vest in equal quarterly installments through 2026, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date.
- F5. Share options granted on August 1, 2023. Includes 24,490 vested options, and 14,694 unvested options, which shall vest in equal quarterly installments through 2027, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date.
- F6. Share options granted on August 20, 2024. Includes 18,228 vested options, and 30,380 unvested options, which shall vest in equal quarterly installments through 2028, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date.
- F7. Share options granted on August 5, 2025. Includes no vested options, and 58,592 unvested options, with one-fourth of the options vesting on August 5, 2026, and the remaining shall vest in equal quarterly installments through 2029, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity holdings does Innoviz (INVZ) CFO Cegla Eldar Mordechay report on Form 3?
He reports direct ownership of 464,053 Ordinary Shares of Innoviz Technologies Ltd. He also holds multiple share option awards and a significant block of restricted share units that may convert into additional Ordinary Shares as they vest over time.
Does the Innoviz (INVZ) CFO Form 3 show any stock purchases or sales?
No purchases or sales are shown; the entries are categorized as holdings. The Form 3 summarizes existing Ordinary Share ownership, share options, and restricted share units, rather than reporting new open-market or derivative transactions during the reported period.
Over what period do the Innoviz (INVZ) CFO’s RSUs vest?
The RSUs referenced in the filing vest in quarterly installments through 2029. Each grant’s vesting is conditioned on the CFO continuing as a service provider on each vesting date, with each RSU representing a right to receive one Ordinary Share.
What does a Form 3 filing like Innoviz (INVZ) CFO’s generally indicate?
A Form 3 typically indicates an insider’s beneficial ownership when they become a reporting person. In this case, it details the CFO’s Ordinary Share holdings, outstanding share options, and restricted share units, providing transparency about his equity-based alignment with Innoviz Technologies Ltd.
AI-generated analysis. How Rhea-AI works. Not financial advice.
